Chemoinformatic Analysis of GRAS (Generally Recognized As Safe) Flavor Chemicals and Natural Products

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Dec 11

PMID 23226386

Citations 12

Authors

Jose L Medina-Franco

Karina Martinez-Mayorga

Terry L Peppard

Alberto Del Rio

Affiliations

Soon will be listed here.

Abstract

Food materials designated as "Generally Recognized as Safe" (GRAS) are attracting the attention of researchers in their attempts to systematically identify compounds with putative health-related benefits. In particular, there is currently a great deal of interest in exploring possible secondary benefits of flavor ingredients, such as those relating to health and wellness. One step in this direction is the comprehensive characterization of the chemical structures contained in databases of flavoring substances. Herein, we report a comprehensive analysis of the recently updated FEMA GRAS list of flavoring substances (discrete chemical entities only). Databases of natural products, approved drugs and a large set of commercial molecules were used as references. Remarkably, natural products continue to be an important source of bioactive compounds for drug discovery and nutraceutical purposes. The comparison of five collections of compounds of interest was performed using molecular properties, rings, atom counts and structural fingerprints. It was found that the molecular size of the GRAS flavoring substances is, in general, smaller cf. members of the other databases analyzed. The lipophilicity profile of the GRAS database, a key property to predict human bioavailability, is similar to approved drugs. Several GRAS chemicals overlap to a broad region of the property space occupied by drugs. The GRAS list analyzed in this work has high structural diversity, comparable to approved drugs, natural products and libraries of screening compounds. This study represents one step towards the use of the distinctive features of the flavoring chemicals contained in the GRAS list and natural products to systematically search for compounds with potential health-related benefits.

Citing Articles

Taurine stimulation of planarian motility: a role for the dopamine receptor pathway.

Livengood E, Fong R, Pratt A, Alinskas V, Van Gorder G, Mezzio M PeerJ. 2024; 12:e18671.

PMID: 39655335 PMC: 11627082. DOI: 10.7717/peerj.18671.

Potential role of Citrus bergamia flower essential oil against oral pathogens.

Imran Aziz M, Hasan M, Ullah R, Bari A, Khan M, Ul Hasnain S BMC Complement Med Ther. 2024; 24(1):157.

PMID: 38609946 PMC: 11010433. DOI: 10.1186/s12906-024-04457-7.

Analysis of a large food chemical database: chemical space, diversity, and complexity.

Naveja J, Rico-Hidalgo M, Medina-Franco J F1000Res. 2018; 7.

PMID: 30135721 PMC: 6081979. DOI: 10.12688/f1000research.15440.2.

Scaffold Diversity of Fungal Metabolites.

Gonzalez-Medina M, Owen J, El-Elimat T, Pearce C, Oberlies N, Figueroa M Front Pharmacol. 2017; 8:180.

PMID: 28420994 PMC: 5376591. DOI: 10.3389/fphar.2017.00180.

Database fingerprint (DFP): an approach to represent molecular databases.

Fernandez-de Gortari E, Garcia-Jacas C, Martinez-Mayorga K, Medina-Franco J J Cheminform. 2017; 9:9.

PMID: 28224019 PMC: 5293704. DOI: 10.1186/s13321-017-0195-1.

References

Feher M, Schmidt J . Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci. 2003; 43(1):218-27. DOI: 10.1021/ci0200467. View

Singh N, Guha R, Giulianotti M, Pinilla C, Houghten R, Medina-Franco J . Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J Chem Inf Model. 2009; 49(4):1010-24. PMC: 2686115. DOI: 10.1021/ci800426u. View

Andreoli F, Moura Barbosa A, Parenti M, Del Rio A . Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives. Curr Pharm Des. 2012; 19(4):578-613. PMC: 3529403. DOI: 10.2174/138161213804581918. View

Lachance H, Wetzel S, Kumar K, Waldmann H . Charting, navigating, and populating natural product chemical space for drug discovery. J Med Chem. 2012; 55(13):5989-6001. DOI: 10.1021/jm300288g. View

Perez-Villanueva J, Santos R, Hernandez-Campos A, Giulianotti M, Castillo R, Medina-Franco J . Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Bioorg Med Chem. 2010; 18(21):7380-91. DOI: 10.1016/j.bmc.2010.09.019. View

Sanders M, Barbosa A, Zarzycka B, Nicolaes G, Klomp J, de Vlieg J . Comparative analysis of pharmacophore screening tools. J Chem Inf Model. 2012; 52(6):1607-20. DOI: 10.1021/ci2005274. View

Ertl P, Roggo S, Schuffenhauer A . Natural product-likeness score and its application for prioritization of compound libraries. J Chem Inf Model. 2007; 48(1):68-74. DOI: 10.1021/ci700286x. View

Bickerton G, Paolini G, Besnard J, Muresan S, Hopkins A . Quantifying the chemical beauty of drugs. Nat Chem. 2012; 4(2):90-8. PMC: 3524573. DOI: 10.1038/nchem.1243. View

Ritchie T, Macdonald S, Young R, Pickett S . The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. Drug Discov Today. 2010; 16(3-4):164-71. DOI: 10.1016/j.drudis.2010.11.014. View

10.

Duan J, Dixon S, Lowrie J, Sherman W . Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods. J Mol Graph Model. 2010; 29(2):157-70. DOI: 10.1016/j.jmgm.2010.05.008. View

11.

Del Rio A, Moura Barbosa A, Caporuscio F, Mangiatordi G . CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes. Mol Biosyst. 2010; 6(11):2122-8. DOI: 10.1039/c0mb00039f. View

12.

Harvey A, Clark R, Mackay S, Johnston B . Current strategies for drug discovery through natural products. Expert Opin Drug Discov. 2012; 5(6):559-68. DOI: 10.1517/17460441.2010.488263. View

13.

Dandapani S, Marcaurelle L . Grand challenge commentary: Accessing new chemical space for 'undruggable' targets. Nat Chem Biol. 2010; 6(12):861-3. DOI: 10.1038/nchembio.479. View

14.

Moura Barbosa A, Del Rio A . Freely accessible databases of commercial compounds for high- throughput virtual screenings. Curr Top Med Chem. 2012; 12(8):866-77. DOI: 10.2174/156802612800166710. View

15.

Scalbert A, Andres-Lacueva C, Arita M, Kroon P, Manach C, Urpi-Sarda M . Databases on food phytochemicals and their health-promoting effects. J Agric Food Chem. 2011; 59(9):4331-48. DOI: 10.1021/jf200591d. View

16.

Lopez-Vallejo F, Nefzi A, Bender A, Owen J, Nabney I, Houghten R . Increased diversity of libraries from libraries: chemoinformatic analysis of bis-diazacyclic libraries. Chem Biol Drug Des. 2011; 77(5):328-42. PMC: 3077462. DOI: 10.1111/j.1747-0285.2011.01100.x. View

17.

Rognan D . Structure-Based Approaches to Target Fishing and Ligand Profiling. Mol Inform. 2016; 29(3):176-87. DOI: 10.1002/minf.200900081. View

18.

Yongye A, Waddell J, Medina-Franco J . Molecular scaffold analysis of natural products databases in the public domain. Chem Biol Drug Des. 2012; 80(5):717-24. DOI: 10.1111/cbdd.12011. View

19.

Ganesan A . The impact of natural products upon modern drug discovery. Curr Opin Chem Biol. 2008; 12(3):306-17. DOI: 10.1016/j.cbpa.2008.03.016. View

20.

Burdock G, Carabin I, Griffiths J . The importance of GRAS to the functional food and nutraceutical industries. Toxicology. 2006; 221(1):17-27. DOI: 10.1016/j.tox.2006.01.012. View